Table 2.
Robustness of miRNA dysregulation in atherosclerosis of different territories.
miRNAs | Reproducibility | Validation and derivation cohorts | Adjustment in multivariate analysis | Diagnostic accuracy |
---|---|---|---|---|
Coronary | ||||
miR-208 | ✓ | ✓ | ||
miR-215 | ✓ | ✓ | ||
miR-487a | ✓ | ✓ | ||
miR-502 | ✓ | ✓ | ||
Let-7 | ✓ | ✓ | ✓ | |
miR-29b | ✓ | ✓ | ||
miR-145 | ✓ | |||
Carotid | ||||
Let-7, miR-30 | ✓ | |||
miR-29c | ✓ | ✓ | ||
miR-21 | ✓ | ✓ | ✓ | ✓ |
miR-27a, miR146a, miR-342-5p, miR-126-3p, miR-181b, miR-320b | ✓ | |||
miR-31, miR-211, miR-218 | ✓ | |||
miR-221 | ✓ | ✓ | ✓ | |
Lower limbs | ||||
miR-15b, miR-16, miR-363 | ✓ | ✓ | ||
miR-25, miR-28-5p, miR-126, miR-26b, miR-195, miR-335 | ✓ | ✓ | ||
miR-27b | ✓ | ✓ | ✓ | |
miR-124, miR-221 | ✓ | ✓ | ||
miR-4739 | ✓ | |||
let7e, miR-20b, miR-4284, miR-432, miR-4463, miR-4306, miR-1827 | ✓ |
For each territory of atherosclerosis, the quality criteria that were met for each miRNA are presented with the symbol ✓.